Record Information |
---|
Version | 2.0 |
---|
Created at | 2022-09-05 18:21:51 UTC |
---|
Updated at | 2022-09-05 18:21:51 UTC |
---|
NP-MRD ID | NP0217877 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | naloxone |
---|
Description | Naloxone, also known as MRZ 2593BR or naloxonum, belongs to the class of organic compounds known as phenanthrenes and derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene. Naloxone is a drug which is used for the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and the narcotic-antagonist analgesics: Nalbuphine, pentazocine and butorphanol. It is also indicated for the diagnosis of suspected acute opioid overdose. It may also be used as an adjunctive agent to increase blood pressure in the management of septic shock. Naloxone is a very strong basic compound (based on its pKa). naloxone is found in Papaver somniferum. naloxone was first documented in 2006 (PMID: 17023477). In humans, naloxone is involved in naloxone action pathway (PMID: 25468814) (PMID: 26469689) (PMID: 26604818). |
---|
Structure | [H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC=C)[C@]([H])(C4)[C@]1(O)CCC2=O InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(-)-Naloxone | ChEBI | 1-N-Allyl-14-hydroxynordihydromorphinone | ChEBI | 17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one | ChEBI | Naloxona | ChEBI | Naloxonum | ChEBI | DBL Naloxone | Kegg | 17-Allyl-3,14-dihydroxy-4,5a-epoxymorphinan-6-one | Generator | 17-Allyl-3,14-dihydroxy-4,5α-epoxymorphinan-6-one | Generator | EN 1530 base | HMDB | L-Naloxone | HMDB | N-Allylnoroxymorphone | HMDB | Nalossone | HMDB | Abello brand OF naloxone hydrochloride | HMDB | Abello, naloxone | HMDB | Boots brand OF naloxone hydrochloride | HMDB | Bristol-myers squibb brand OF naloxone hydrochloride | HMDB | Curamed brand OF naloxone hydrochloride | HMDB | endo Brand OF naloxone hydrochloride | HMDB | Narcanti | HMDB | Ratiopharm brand OF naloxone hydrochloride | HMDB | Dihydride, naloxone hydrochloride | HMDB | Naloxon ratiopharm | HMDB | Naloxone hydrochloride | HMDB | Naloxone hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-isomer | HMDB | SERB brand OF naloxone hydrochloride | HMDB | Bristol myers squibb brand OF naloxone hydrochloride | HMDB | Curamed, naloxon | HMDB | Lamepro brand OF naloxone hydrochloride | HMDB | MRZ 2593BR | HMDB | Nalone | HMDB | Naloxon-ratiopharm | HMDB | Hydrobromide, naloxone | HMDB | Hydrochloride dihydride, naloxone | HMDB | Hydrochloride, naloxone | HMDB | MRZ 2593 BR | HMDB | MRZ 2593-BR | HMDB | Naloxon curamed | HMDB | Naloxone abello | HMDB | Naloxone hydrochloride dihydride | HMDB | Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-isomer | HMDB | Naloxonratiopharm | HMDB | Naloxone hydrobromide | HMDB | Narcan | HMDB | United drug brand OF naloxone hydrochloride | HMDB |
|
---|
Chemical Formula | C19H21NO4 |
---|
Average Mass | 327.3743 Da |
---|
Monoisotopic Mass | 327.14706 Da |
---|
IUPAC Name | (1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-trien-14-one |
---|
Traditional Name | naloxone |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC=C)[C@]([H])(C4)[C@]1(O)CCC2=O |
---|
InChI Identifier | InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1 |
---|
InChI Key | UZHSEJADLWPNLE-GRGSLBFTSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenanthrenes and derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenanthrenes and derivatives |
---|
Sub Class | Not Available |
---|
Direct Parent | Phenanthrenes and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Phenanthrene
- Isoquinolone
- Tetralin
- Coumaran
- 1-hydroxy-2-unsubstituted benzenoid
- Alkyl aryl ether
- Aralkylamine
- Piperidine
- Cyclic alcohol
- Tertiary alcohol
- 1,2-aminoalcohol
- Ketone
- Tertiary aliphatic amine
- Tertiary amine
- Ether
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organic nitrogen compound
- Organopnictogen compound
- Carbonyl group
- Organooxygen compound
- Alcohol
- Organic oxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|